Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The continued evolution of drugs for psoriasis.

Feldman SR.

J Drugs Dermatol. 2013 Aug;12(8):850-1. No abstract available.

PMID:
23986155
2.

The topical treatment of psoriasis.

van de Kerkhof PC.

Clin Exp Dermatol. 2005 Mar;30(2):205-8. Review. No abstract available.

PMID:
15725262
3.

Topical therapy for psoriasis.

Lebwohl M, Abel E, Zanolli M, Koo J, Drake L.

Int J Dermatol. 1995 Oct;34(10):673-84. Review. No abstract available.

PMID:
8537153
4.

Drug delivery and formulations for the topical treatment of psoriasis.

Su YH, Fang JY.

Expert Opin Drug Deliv. 2008 Feb;5(2):235-49. doi: 10.1517/17425247.5.2.235. Review.

PMID:
18248321
5.

A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.

Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R, Moore J.

J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):268-9. No abstract available.

PMID:
8708035
6.

Effect of topical miconazole in plaque psoriasis.

Niczyporuk W, Krajewska-Kułak E.

Rocz Akad Med Bialymst. 1997;42(1):236-40.

PMID:
9581486
7.

[Psoriasis--clinical picture and current therapy].

Shakery K, Reich K.

Med Monatsschr Pharm. 2009 Sep;32(9):335-44; quiz 345-6. Review. German.

PMID:
19795696
8.

An open trial of topical urocanic acid for the treatment of stable plaque psoriasis.

Vestey JP, Norval M.

Photodermatol Photoimmunol Photomed. 1997 Feb-Apr;13(1-2):67-8. No abstract available.

PMID:
9361132
9.

Pediatric psoriasis.

Busch AL, Landau JM, Moody MN, Goldberg LH.

Skin Therapy Lett. 2012 Jan;17(1):5-7.

10.

Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.

Pariser DM, Pariser RJ, Breneman D, Lebwohl M, Kalb R, Moore J, Moss H, Parker C, Fiedler V.

Arch Dermatol. 1996 Dec;132(12):1527. No abstract available.

PMID:
8961897
11.

Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment.

Abramovits W, Perlmutter A, Gupta AK.

Skinmed. 2006 May-Jun;5(3):136-8. No abstract available.

PMID:
16687982
12.

Topical psoriasis therapy.

Federman DG, Froelich CW, Kirsner RS.

Am Fam Physician. 1999 Feb 15;59(4):957-62, 964. Review.

13.

Management of psoriasis with calcipotriol used as monotherapy.

Ramsay CA.

J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S53-4. Review.

PMID:
9344185
14.

Pimecrolimus for psoriasis.

Ayer J, Young HS.

Expert Opin Pharmacother. 2013 Apr;14(6):767-74. doi: 10.1517/14656566.2013.775247. Epub 2013 Mar 6. Review.

PMID:
23461536
15.

A cost-effectiveness comparison of liquor carbonis distillate solution and calcipotriol cream in the treatment of moderate chronic plaque psoriasis.

Alora-Palli MB, Brouda I, Green B, Kimball AB.

Arch Dermatol. 2010 Aug;146(8):919-22. doi: 10.1001/archdermatol.2010.167. No abstract available.

PMID:
20713833
16.

[Mechanism of action of internally administered drugs in psoriasis].

Novotný F.

Cesk Dermatol. 1975 Dec;50(6):395-401. Czech. No abstract available.

PMID:
1192482
17.

Advances in topical therapy for skin diseases.

Willsteed EM.

Med J Aust. 1996 Sep 2;165(5):274-9. Review. No abstract available.

PMID:
8816688
18.
19.

[Current status of the treatment of psoriasis?].

Touraine R.

Rev Prat. 1974 Apr 21;24(23):2141-4, 2147-8. French. No abstract available.

PMID:
4416969
20.

Clearance in psoriasis treatment.

Kumar B, Saraswat A.

J Am Acad Dermatol. 2001 Jul;45(1):153-4. No abstract available.

PMID:
11423858

Supplemental Content

Support Center